In this issue:
Safety lead-in results from the BEACON CRC study
Serious illness communications between clinicians & patients
Effect of the Serious Illness Care Program in outpatient oncology
Gemcitabine, cisplatin + nab-paclitaxel in advanced BTCs
mFOLFOX + ziv-aflibercept in mGOC
Adding panitumumab or rilotumumab to mFOLFOX6 in mGOC
Coffee consumption reduces HCC risk
Clinical and molecular features of early-onset CRC
SMS intervention improves colonoscopy adherence
Telephone vs in-person counselling for CRC
Please login below to download this issue (PDF)